This activity will identify the multifaceted effects of past and continuous trauma—including collective and racial trauma—on the well-being of individuals, cultures, communities, and social environments. It will review racism and oppressive tendencies and present strategies to skillfully manage difficult racial and cultural situations and their associated stressful responses. Importantly, trauma management therapies and practices will be identified, along with approaches to building communal anti-racist culture within the workplace. 

This session will examine the genetic approaches being explored for these diseases, such as the introduction of a corrected or modified β-globin gene and gene-sequence editing. It will also explore the genetic modalities utilized, such as genome-editing technologies including the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene-editing system and lentiviral vectors. The safety, efficacy and challenges associated with these therapies will also be outlined.

This activity will explore recent advances in the diagnosis and treatment of Pompe disease and other LSDs, including current clinical trials. It will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s) and highlight the role of the interprofessional team in evaluating and improving care for patients with these conditions.

This activity will provide participants with the latest science on monkeypox, describing the spectrum of associated symptoms and signs, virulence, and common routes of transmission. Discussion will also focus on the factors driving this outbreak, approaches to prevention and management, and an overview of the impact of this disease globally and in comparison with the current COVID-19 public health emergency.